Acceleration

An effective analysis of the technology and target markets plays a key role in deciding to start development. It is important to make sure that the new solution will be safer and more effective than existing ones. It is also necessary to determine the target population, indications for use, conduct an epidemiological analysis, estimate the potential number of patients, and understand how well the future development will meet the profit targets of the company’s business model.

Comprehensive analysis, evaluation, and market launch of developments:

• genetic research,
• vaccines,
• umbilical cord blood banks,
• reproductive material donor banks,
• lower limb ischemia,
• bone grafting materials,
• orphan diseases.

The beginning of development in a biotech startup is in many ways similar to R&D activities of research institutes and fundamental science. However, the tasks and principles of conducting preclinical and clinical trials (PCTs and CTs) are fundamentally different and impose special requirements on the quality and content of prior studies.

The competencies and experience of Artgen’s experts help the companies within our ecosystem set correct goals, optimize design, and select partners to conduct trials from the very first stages."

Developed technology platforms:

• Betusphere.
• Neovasculgen.
• Histograft.

Completed all development stages:

• Neovasculgen.
• ГHistograft.
• SPRS Therapy

At the CT stage:

• Neovasculgen (indication expansion).
• Histograft (platform products).
• Betuvax.
• Tetraflubet.

The process of creating and managing a company’s patent portfolio in order to provide strong patent protection while maintaining freedom to operate the invention.

Any startup requires standard business processes such as management, legal services, accounting, financial analysis and planning, human resource management, procurement, etc. In addition to standard competencies, specific aspects of the biotech industry must also be taken into account to effectively manage a biotech company.

• Accounting support.
• Corporate lawyers.
• Personnel management.
• Recruitment and onboarding.
• Procurement and logistics.
• Patent support.
• Financial analysis.
• Planning.
• Budgeting.
• IT support.
• Brand management.
• PR, IR, GR.

"Development institutes play an important part in supporting businesses, implementing innovations, and creating favorable conditions for sustainable economic growth. However, interaction with them is carefully regulated and requires accountability. Relevant competencies and well-established business processes are required to obtain support. Many support measures for biotech companies have been implemented in the country at the initiative of Artgen’s management.

Companies within Artgen’s ecosystem can effectively interact with development institutes thanks to the efficient communication experience, knowledge of the processes and practices of their use.

"The investment cycle in the biotech sector is the longest among deep technologies. From the very first R&D stages, the development of biotech startups requires significant and long-term investments which are extremely difficult to attract without relevant expertise and experience.

Artgen’s ecosystem makes it easier for its participants to access seed capital either by using its own direct investments or by providing assistance and support in attracting private investors, venture capital funds, convertible loans, or grants.

The structuring of seed investments goes alongside with calculating the need and preparing companies for the following financing rounds in the form of Pre-IPO, IPO, or bond loans.

IPO on Moscow Stock Exchange

Venture investments

Bonds on Moscow Stock Exchange

Loans